Medlanes Company

Biosensor technologyLucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving laboratory-quality results. The company's biosensors are based on the invention of a new type of biochemical sensing molecule. A light-producing enzyme calledLucentix - Crunchbase Company Profile & Fundingwww.crunchbase.com/organization/lucentixБыл ли этот ответ полезен?

Headquarters: Germany
Funding Status: Early Stage Venture
Employee Number: 25
Estimated Revenue: $1M to $10M
Technology: Other type
Investor Type: For Profit
Founded Date: 2013
Industry: Diagnostics and Prognostics